NURIX THERAPEUTICS INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$26.80
-1.18%
Yahoo Finance · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
+14.8%
3 months
+15.4%
6 months
+59.4%
1 year
+109.7%
Year to date
+41.3%
52-week range
$12.17 – $27.79
Fundamental snapshot
Latest reported period: Aug 31, 2026
Market cap
$2.93B
P/E
9.9
P/B
3
P/S
4.2
Revenue
$701.94M
Net income
$294.88M
Diluted EPS
2.3
Gross margin
100.00%
Net margin
42.00%
Return on equity
49.30%
Total debt
$65.33M
Cash
$721.02M
Free cash flow
$369.81M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Aug 31, 2026 | $673.06M | $549.81M | 100.00% | 81.70% | $614.24M |
| May 31, 2026 | $9.04M | -$89.54M | 100.00% | -990.10% | -$98.51M |
| Feb 28, 2026 | $6.25M | -$87.17M | 100.00% | -1394.30% | -$72.96M |
| Nov 30, 2025 | $13.58M | -$78.22M | 100.00% | -576.10% | -$72.96M |
| Aug 31, 2025 | $7.89M | -$86.42M | 100.00% | -1094.80% | -$60.1M |
| May 31, 2025 | $44.06M | -$43.46M | 100.00% | -98.70% | -$65.84M |
| Feb 28, 2025 | $18.45M | -$56.35M | 100.00% | -305.40% | -$64.57M |
| Nov 30, 2024 | $13.28M | -$58.55M | 100.00% | -440.70% | -$50.86M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent NRIX news
All market newsNo ticker-linked stories are in the current archive.